8-K: Option Care Health Reports Solid 2025 Results, Positive 2026 Outlook

Option Care Health, Inc. announced strong full-year 2025 revenue growth and positive 2026 financial guidance, despite a slight dip in GAAP net income.

Summary

• Net revenue for Q4 2025 reached $1,465.4 million, an 8.8% increase year-over-year.
• Full-year 2025 net revenue was $5,649.5 million, up 13.0% from the previous year.
• GAAP diluted earnings per share for Q4 2025 was $0.37, a 5.7% increase, and $1.27 for the full year, up 3.3%.
• Adjusted EBITDA for Q4 2025 grew 3.7% to $126.0 million, and for the full year 2025, it increased 6.2% to $471.3 million.
• Adjusted diluted earnings per share was $0.46 for Q4 2025 (up 4.5%) and $1.72 for the full year 2025 (up 8.9%).
• Net income for Q4 2025 was $58.5 million, a 2.7% decrease, and $207.6 million for the full year, down 2.0%.
• Cash provided by operating activities for the full year 2025 was $258.4 million.
• The company repurchased $95 million of stock in Q4 2025 and $307 million for the full year 2025.
• Option Care Health served over 315,000 patients during 2025.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, driven by strong revenue growth, positive adjusted earnings, and optimistic 2026 guidance, despite a slight decline in GAAP net income and operating cash flow.

Positives

• Strong net revenue growth of 8.8% in Q4 2025 and 13.0% for the full year 2025, indicating robust demand for services.
• Growth in GAAP diluted EPS (5.7% in Q4, 3.3% full year) and Adjusted diluted EPS (4.5% in Q4, 8.9% full year) demonstrates improved profitability on a per-share basis.
• Adjusted EBITDA increased by 3.7% in Q4 2025 and 6.2% for the full year 2025, reflecting operational efficiency.
• Significant stock repurchases of $95 million in Q4 and $307 million for the full year 2025, signaling management's confidence and returning value to shareholders.
• Positive financial guidance for full year 2026, projecting net revenue of $5.8 billion to $6.0 billion, adjusted diluted EPS of $1.82 to $1.92, and adjusted EBITDA of $480 million to $505 million.
• Projected cash provided by operating activities of at least $340 million for 2026, indicating strong future cash generation.

Negatives

• Net income decreased by 2.7% in Q4 2025 to $58.5 million and by 2.0% for the full year 2025 to $207.6 million, despite revenue growth.
• Cash provided by operating activities for the full year 2025 decreased to $258.4 million from $323.392 million in 2024.
• Cash and cash equivalents decreased significantly from $412.565 million at December 31, 2024, to $232.624 million at December 31, 2025.
• Long-term debt, net, increased to $1,154.052 million at December 31, 2025, from $1,104.641 million at December 31, 2024.

Risks

• Changes in laws, regulations, or trade policies applicable to the business model.
• Loss of relationships with managed care organizations and other non-governmental third-party payers.
• Changes in the pharmaceutical industry, including limiting or discontinuing research, development, production, and marketing of pharmaceuticals compatible with services.
• Changes in market conditions and receptivity to services and offerings.
• Pending and future litigation or potential liability for claims not covered by insurance.

Future Outlook

For the full year 2026, Option Care Health expects net revenue between $5.8 billion and $6.0 billion, adjusted diluted earnings per share of $1.82 to $1.92, adjusted EBITDA of $480 million to $505 million, and cash provided by operating activities of at least $340 million.

Management Comments

• Our team continued to execute at a very high level to deliver extraordinary care and solid results in the fourth quarter and full year of 2025.
• During 2025, we served over 315,000 patients and they remain at the center of everything we do.
• We continued to make significant progress against our key priorities to build a sustainable growth enterprise while navigating a dynamic industry environment.
• As we look ahead in 2026, I am excited about the opportunities to further our mission and capitalize on the positive long-term growth trends across our industry and the strength of our position to serve more patients.

Industry Context

StockSavvy.ai notes that Option Care Health, as the nation's largest independent provider of home and alternate site infusion services, is well-positioned to capitalize on the growing trend towards home-based healthcare. The company's consistent revenue growth and positive outlook for 2026 suggest it is effectively navigating the dynamic industry environment and leveraging its scale and clinical expertise to serve a large patient base.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Benefit from significant stock repurchases and positive future guidance, potentially leading to increased share value.
• Patients: The company served over 315,000 patients in 2025, indicating continued delivery of care.
• Employees/Clinicians: The company has over 8,000 team members, including more than 5,000 clinicians, suggesting stable employment and continued operational activity.

Next Steps

• Option Care Health will host a conference call on February 24, 2026, at 8:30 a.m. ET to discuss these results.

Key Dates

Recommendation

The company demonstrates strong revenue growth, robust adjusted financial metrics, and a positive outlook for 2026, indicating a healthy underlying business. The significant share repurchases reflect management's confidence. While GAAP net income saw a slight decline and operating cash flow decreased, the overall trajectory and market position as the largest independent provider in a growing sector suggest strong long-term potential for investors.

Keywords

Home Infusion, Alternate Site Infusion, Healthcare Services, Specialty Pharmacy, Financial Results, Earnings, EBITDA, EPS, Stock Repurchase, Guidance, OPCH